Episode Details
Back to Episodes
Stem Cell Therapy Slows Kidney Decline | Galway News
Description
A breakthrough stem cell therapy from Galway-based Orbsen Therapeutics shows early promise in slowing kidney damage from type 2 diabetes—potentially delaying or even preventing the need for dialysis or transplants. In a 18-month trial, a single IV dose of ORBCEL-M preserved kidney function better than expected, sparking optimism for larger studies that could redefine care for millions living with progressive kidney disease.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/8e5a4298b888ee1a